Raymond James Trust’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$859K Buy
21,185
+838
+4% +$31.5K 0.02% 551
2024
Q2
$704K Buy
20,347
+420
+2% +$15.5K 0.02% 588
2024
Q1
$749K Buy
19,927
+503
+3% +$18K 0.02% 554
2023
Q4
$697K Sell
19,424
-459
-2% -$17.7K 0.02% 560
2023
Q3
$751K Sell
19,883
-2,172
-10% -$88.5K 0.02% 497
2023
Q2
$898K Buy
22,055
+23
+0.1% +$951 0.03% 457
2023
Q1
$923K Buy
22,032
+1,429
+7% +$59.6K 0.03% 428
2022
Q4
$891K Buy
20,603
+5,549
+37% +$219K 0.03% 427
2022
Q3
$564K Sell
15,054
-3,383
-18% -$150K 0.02% 544
2022
Q2
$835K Sell
18,437
-813
-4% -$38.2K 0.03% 421
2022
Q1
$917K Sell
19,250
-10,442
-35% -$442K 0.03% 434
2021
Q4
$1.22M Sell
29,692
-3,872
-12% -$146K 0.04% 368
2021
Q3
$1.16M Buy
33,564
+1,535
+5% +$52.5K 0.04% 366
2021
Q2
$1.01M Buy
32,029
+372
+1% +$12K 0.03% 399
2021
Q1
$987K Buy
31,657
+1,468
+5% +$44.1K 0.03% 380
2020
Q4
$909K Buy
30,189
+9,076
+43% +$268K 0.03% 377
2020
Q3
$538K Sell
21,113
-3,454
-14% -$91.6K 0.02% 476
2020
Q2
$636K Buy
24,567
+1,252
+5% +$33.2K 0.03% 398
2020
Q1
$613K Sell
23,315
-2,400
-9% -$75.5K 0.04% 360
2019
Q4
$837K Sell
25,715
-139
-0.5% -$4.5K 0.04% 344
2019
Q3
$891K Sell
25,854
-3,822
-13% -$128K 0.05% 320
2019
Q2
$1.01M Sell
29,676
-1,077
-4% -$38K 0.06% 287
2019
Q1
$1.1M Sell
30,753
-2,093
-6% -$71.3K 0.06% 260
2018
Q4
$1.06M Buy
32,846
+538
+2% +$17.2K 0.07% 250
2018
Q3
$1.01M Sell
32,308
-361
-1% -$11.1K 0.06% 281
2018
Q2
$993K Buy
32,669
+3,660
+13% +$105K 0.06% 267
2018
Q1
$807K Sell
29,009
-690
-2% -$18.6K 0.06% 276
2017
Q4
$835K Sell
29,699
-7,294
-20% -$210K 0.06% 274
2017
Q3
$994K Sell
36,993
-679
-2% -$18.2K 0.07% 240
2017
Q2
$969K Sell
37,672
-2,327
-6% -$59.2K 0.07% 245
2017
Q1
$1.03M Buy
39,999
+1,067
+3% +$27.2K 0.08% 236
2016
Q4
$986K Sell
38,932
-963
-2% -$22.8K 0.08% 233
2016
Q3
$947K Buy
39,895
+24
+0.1% +$603 0.08% 225
2016
Q2
$1.03M Buy
39,871
+431
+1% +$10.7K 0.09% 208
2016
Q1
$1.01M Buy
39,440
+2,838
+8% +$63.6K 0.09% 204
2015
Q4
$725K Sell
36,602
-100
-0.3% -$2.03K 0.07% 268
2015
Q3
$778K Sell
36,702
-1,612
-4% -$36.2K 0.09% 222
2015
Q2
$859K Buy
38,314
+3,908
+11% +$93.6K 0.09% 216
2015
Q1
$825K Sell
34,406
-1,108
-3% -$27.4K 0.09% 228
2014
Q4
$939K Buy
35,514
+1,860
+6% +$47.7K 0.1% 207
2014
Q3
$818K Buy
33,654
+362
+1% +$8.48K 0.09% 213
2014
Q2
$866K Buy
33,292
+548
+2% +$14K 0.1% 207
2014
Q1
$783K Buy
32,744
+4,105
+14% +$86.4K 0.1% 210
2013
Q4
$559K Sell
28,639
-2,184
-7% -$43.9K 0.07% 248
2013
Q3
$652K Sell
30,823
-3,152
-9% -$69K 0.1% 204
2013
Q2
$749K Buy
+33,975
New +$824K 0.12% 178

Other funds holding EXC

Raymond James Trust's EXC Position: Q3 2024 in Review

Raymond James Trust increased its Exelon (EXC) stake by 4.1% in Q3 2024, buying an estimated $31.5K and bringing the position to 21,185 shares worth $859K. The position accounts for 0.02% of the portfolio, ranked #551.

Raymond James Trust first reported a position in EXC in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.22M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold EXC as of Q3 2024.

  • Raymond James Trust held 21,185 shares of Exelon worth $859K as of Q3 2024.
  • Raymond James Trust bought 838 Exelon shares in Q3 2024, an estimated $31.5K.
  • Exelon made up 0.02% of Raymond James Trust's portfolio in Q3 2024, its #551 holding.
  • Raymond James Trust first reported a position in Exelon in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Trust's Exelon position peaked at $1.22M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Exelon as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.